Psyence Biomedical (PBM) Intangibles (2026)
Psyence Biomedical (PBM) posted Intangibles of $389758.0 for Q1 2026.
Powered by 
Analysis
Psyence Biomedical (PBM) Intangibles (2026) Analysis & Trends
Psyence Biomedical has reported Intangibles for 1 years, with the latest figure at $389758.0 in Q1 2026.
- On a quarterly basis, Intangibles changed N/A year-over-year to $389758.0 in Q1 2026; TTM through Mar 2026 was $389758.0, a N/A change from a year earlier, with the FY2026 full-year figure at $389758.0, changed N/A from the prior year.
- Intangibles was $389758.0 for Q1 2026 at Psyence Biomedical.
- The five-year high for Intangibles was $389758.0 in Q1 2026, with the low at $389758.0 in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.54 Bn | 192.56 Bn | 7.24 Bn | 20.49 Bn |
| 2 | Gilead Sciences | 179.55 Bn | 176.37 Bn | 6.22 Bn | 14.03 Bn |
| 3 | Vertex Pharmaceuticals | 131.10 Bn | 123.25 Bn | 2.84 Bn | 412.80 Mn |
| 4 | Regeneron Pharmaceuticals | 81.61 Bn | 73.62 Bn | 3.93 Bn | 1.31 Bn |
| 5 | Argenx Se | 60.69 Bn | 55.51 Bn | 1.37 Bn | 266.00 Mn |
| 6 | Moderna | 53.54 Bn | 48.40 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.41 Bn | 30.10 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.80 Bn | 30.52 Bn | 1.96 Bn | 13.52 Bn |
| 9 | Roivant Sciences | 29.08 Bn | 29.08 Bn | 1.16 Mn | - |
| 10 | Psyence Biomedical | 2.64 Mn | 2.64 Mn | - | 389,758.00 |